ATLANTA—Two oral drugs, molnupiravir and paxlovid (nirmatrelvir/ritonavir), provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results